CompletedPHASE2, PHASE3NCT00759525
The Role of Mineralocorticoid Receptors in Vascular Function
Studying Apparent mineralocorticoid excess
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Brigham and Women's Hospital
- Principal Investigator
- Joshua A Beckman, MD, APRN MSNBrigham and Women's Hospital
- Intervention
- Glycyrrhetic Acid(drug)
- Enrollment
- 15 enrolled
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2002 – 2009
Study locations (1)
- Brigham and Women's Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00759525 on ClinicalTrials.gov